Artículos del autor

solaci

Acute coronary syndromes

EuroPCR 2018 | FFR Reduces Death and Infarction Rates Compared with Medical Treatment

Pooled data from the most important recently published studies (FAME 2, Compare-Acute, and DANAMI3-PRIMULTI) conclude that there...
solaci -
Chronic Ischemic cardiopathy

EuroPCR 2018 | FAME 2: FFR Shows 5-Year Benefit for Hard Endpoints

After a 5-year follow-up, and for the first time, functional assessment with fractional flow reserve (FFR) showed...
solaci -
Peripheral vascular disease

Antithrombotics after Venous Stenting: Rather Different from Coronary Artery Stenting

Should the Antithrombotic/antiplatelet therapy following 10.0 by 60 mm stent implantation to the subclavian vein of a...
solaci -
Chronic Ischemic cardiopathy

EuroPCR 2018 | ORBITA: The Link Between Ischemia and Symptoms Is Still Not Entirely Understood

Invasive physiology tests used in the ORBITA trial could not predict which patients would benefit from angioplasty...
solaci -
Chronic Ischemic cardiopathy

EuroPCR 2018 | SYNTAX III REVOLUTION: Excellent Correlation Between Angiography and Computerized Tomography in Patients with Left Main and Multivessel Disease

In patients with left main or three-vessel coronary disease, heart team decisions on revascularization strategy (angioplasty or...
solaci -
Chronic Ischemic cardiopathy

EuroPCR 2018 | SCAAR Registry at 10 years: FFR improves decision making in the long term

The SCAAR registry aimed at showing the differences in mortality at very long term when using functional...
solaci -
EuroPCR 2018

EuroPCR 2018

Here you will find the highlights of the EuroPCR 2018, held on May 22-25 in the city...
solaci -
Structural heart disease

Is TAVR Durable Beyond 5 Years?

Courtesy of Dr. Carlos Fava. The benefits derived from transcatheter aortic valve replacement (TAVR) are clear and self-evident, and...
solaci -